Palapas, Randie Arnoldelle J.
HRN: 19-94-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2022
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
06/23/2022
06/30/2022
PO
3ml
Q12
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes